+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Phase 2
Age: 18Years +
All Genders
ID05320198

Evaluation of DISC-0974 for Safety, Pharmacokinetics, and Clinical Activity in Adults with Myelofibrosis or Myelodysplastic Syndrome and Anemia

Led by Disc Medicine, Inc · Updated on 2026-10-22

150

Participants Needed

35

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and clinical activity of DISC-0974 in people with myelofibrosis or myelodysplastic syndrome who also have anemia. This phase 1b2a open-label study aims to understand how DISC-0974 affects hematologic response in these participants, including its impact on anemia and transfusion dependence. DISC-0974 is given as a subcutaneous injection every four weeks during both the phase 1b dose-escalation and phase 2 expansion parts of the study. The study evaluates different cohorts based on transfusion dependence and anemia status, with doses administered repeatedly up to day 169. Participants continue stable dosing of other therapies for myelofibrosis as allowed, and certain washout periods are required before screening. Participants will be involved in regular assessments including blood and urine tests to monitor safety and treatment effects from day 1 through day 169. Researchers measure anemia response, transfusion independence, hematologic parameters, pharmacodynamics markers, and safety outcomes such as vital signs and adverse events. The study includes monitoring of quality of life related to anemia and fatigue. Overall participation may last several months, with detailed evaluations during treatment.

CONDITIONS

Brief Title

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

Research Team

D

Disc Medicine Clinical Trials

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here